Introduction: Oral squamous cell carcinoma has a high incidence and, although elective neck dissection is recommended, the removed nodes frequently present without metastasis. This surgical approach causes disabilities and increases possible surgical complications. Objective: To evaluate the possibility of a watchful waiting approach in oral cancer. Methods: We compared 78 patients with clinical and pathological node metastases and their counterparts with pathological node metastases but without evident clinical neck disease. Therefore, we provided a theoretical comparison between the patients who had an elective neck dissection and those who waited until a clinically positive node was evident. Results: The prognostic factor rates were similar between the groups. Their regional recurrence and mortality rates had no statistical differences. Conclusion: A watchful waiting policy could be applied to selected oral cancer patients who can undergo a very close follow-up. This option would be more cost-effective and less harmful than elective neck dissection.

Keywords:
Epidermoid cancer, Head and neck cancer, Oral carcinoma, Neck dissection
1.
Siegel RL, Miller KD, Jemal A: Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7–30.
2.
Antoniades DZ, Styanidis K, Papanayotou P, Trigonidis G: Squamous cell carcinoma of the lips in a northern Greek population. Evaluation of prognostic factors on 5-year survival rate. I. Eur J Cancer B Oral Oncol 1995; 31b: 333–339.
3.
Gupta K, Metgud R: Evidences suggesting involvement of viruses in oral squamous cell carcinoma. Patholog Res Int 2013; 2013: 642496.
4.
Contaldo M, Di Napoli A, Pannone G, Franco R, Ionna F, Feola A, De Rosa A, Santoro A, Sbordone C, Longo F, Pasquali D, Loreto C, Ricciardiello F, Esposito G, D’Angelo L, Itro A, Bufo P, Tombolini V, Serpico R, Di Domenico M: Prognostic implications of node metastatic features in OSCC: a retrospective study on 121 neck dissections. Oncol Rep 2013; 30: 2697–2704.
5.
Amar A, Rapoport A, Curioni OA, Dedivitis RA, Cernea CR, Brandao LG: Prognostic value of regional metastasis in squamous cell carcinoma of the tongue and floor of mouth. Braz J Otorhinolaryngol 2013; 79: 734–737.
6.
Yuen AP, Wei WI, Wong YM, Tang KC: Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck 1997; 19: 583–588.
7.
Cheng A, Schmidt BL: Management of the N0 neck in oral squamous cell carcinoma. Oral Maxillofac Surg Clin North Am 2008; 20: 477–497.
8.
Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Brazilian Head and Neck Cancer Study Group. Am J Surg 1998; 176: 422–427.
9.
Canis M, Pluquett S, Ihler F, Matthias C, Kron M, Steiner W: Impact of elective neck dissection vs observation on regional recurrence and survival in cN0-staged patients with squamous cell carcinomas of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg 2012; 138: 650–655.
10.
Weiss MH, Harrison LB, Isaacs RS: Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 1994; 120: 699–702.
11.
Dias FL, Kligerman J, Matos de Sa G, Arcuri RA, Freitas EQ, Farias T, Matos F, Lima RA: Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 2001; 125: 23–29.
12.
Greenberg JS, El Naggar AK, Mo V, Roberts D, Myers JN: Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making. Cancer 2003; 98: 508–515.
13.
Andersen PE, Cambronero E, Shaha AR, Shah JP: The extent of neck disease after regional failure during observation of the N0 neck. Am J Surg 1996; 172: 689–691.
14.
Stoeckli SJ, Alkureishi LW, Ross GL: Sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2009; 266: 787–793.
15.
Ying M, Bhatia KS, Lee YP, Yuen HY, Ahuja AT: Review of ultrasonography of malignant neck nodes: greyscale, Doppler, contrast enhancement and elastography. Cancer Imaging 2014; 13: 658–669.
16.
Rodrigo JP, Shah JP, Silver CE, Medina JE, Takes RP, Robbins KT, Rinaldo A, Werner JA, Ferlito A: Management of the clinically negative neck in early-stage head and neck cancers after transoral resection. Head Neck 2011; 33: 1210–1219.
17.
Kligerman J, Lima RA, Soares JR, Prado L, Dias FL, Freitas EQ, Olivatto LO: Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg 1994; 168: 391–394.
18.
Yuen AP, Ho CM, Chow TL, Tang LC, Cheung WY, Ng RW, Wei WI, Kong CK, Book KS, Yuen WC, Lam AK, Yuen NW, Trendell-Smith NJ, Chan YW, Wong BY, Li GK, Ho AC, Ho WK, Wong SY, Yao TJ: Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck 2009; 31: 765–772.
19.
D’Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, Agarwal JP, Pantvaidya G, Chaukar D, Deshmukh A, Kane S, Arya S, Ghosh-Laskar S, Chaturvedi P, Pai P, Nair S, Nair D, Badwe R: Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 2015; 373: 521–529.
20.
Fakih AR, Rao RS, Borges AM, Patel AR: Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg 1989; 158: 309–313.
21.
Vandenbrouck C, Sancho-Garnier H, Chassagne D, Saravane D, Cachin Y, Micheau C: Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity: results of a randomized clinical trial. Cancer 1980; 46: 386–390.
22.
El Ghani F, Van Den Brekel MW, De Goede CJ, Kuik J, Leemans CR, Smeele LE: Shoulder function and patient well-being after various types of neck dissections. Clin Otolaryngol Allied Sci 2002; 27: 403–408.
23.
Shivakumar K, Vipin G, Suraj M, Rajaram BV, Rakesh R, Anuradha A, Hemanth K: Sentinel lymph node biopsy in N0 neck for squamous cell carcinoma of oral cavity: a prospective study. Indian J Surg Oncol 2016; 7: 375–379.
24.
O’Connor R, Pezier T, Schilling C, McGurk M: The relative cost of sentinel lymph node biopsy in early oral cancer. J Craniomaxillofac Surg 2013; 41: 721–727.
25.
Payoux P, Dekeister C, Lopez R, Lauwers F, Esquerre JP, Paoli JR: Effectiveness of lymphoscintigraphic sentinel node detection for cervical staging of patients with squamous cell carcinoma of the head and neck. J Oral Maxillofac Surg 2005; 63: 1091–1095.
26.
Amit M, Yen TC, Liao CT, Chaturvedi P, Agarwal JP, Kowalski LP, Kohler HF, Ebrahimi A, Clark JR, Cernea CR, Brandao JS, Kreppel M, Zoller JE, Leider-Trejo L, Bachar G, Shpitzer T, Bolzoni AV, Patel RP, Jonnalagadda S, Robbins TK, Shah JP, Patel SG, Gil Z: The origin of regional failure in oral cavity squamous cell carcinoma with pathologically negative neck metastases. JAMA Otolaryngol Head Neck Surg 2014; 140: 1130–1137.
27.
Medina JE, Byers RM: Supraomohyoid neck dissection: rationale, indications, and surgical technique. Head Neck 1989; 11: 111–122.
28.
Roxburgh CS, McMillan DC: Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010; 6: 149–163.
29.
Chang KP, Chang YT, Liao CT, Yen TC, Chen IH, Chang YL, Liu YL, Chang YS, Yu JS, Wu CC: Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling. Clin Chim Acta 2011; 412: 980–987.
30.
Nakashima H, Matsuoka Y, Yoshida R, Nagata M, Hirosue A, Kawahara K, Sakata J, Arita H, Hiraki A, Nakayama H: Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study. BMC Cancer 2016; 16: 41.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.